China’s CDE Unveils Technical Guidelines for Stem Cell Products and Immunotherapy in Chronic Hepatitis B
The Center for Drug Evaluation (CDE) has released a series of Technical Guidelines aimed at...
Policy / Regulatory
NMPA Mandates Label Updates for 11 Drug Varieties Including Black Box Warnings
The National Medical Products Administration (NMPA) has released 10 notifications regarding revisions to package inserts...
Jiangsu Initiates Price Negotiations for Provincial Stock Drugs, Addresses Shortages
The Jiangsu Public Resource Trading Platform has released a notification indicating the commencement of price...
China’s NHC Advances Enhanced Recovery After Surgery (ERAS) Protocols Nationwide
The National Health Commission (NHC) has released a notification with the goal of promoting enhanced...
NMPA’s 2022 Drug Supervision Report: Clinical Trials and Market Filings on the Rise
The National Medical Products Administration (NMPA) has released its “Annual Drug Supervision and Administration Statistics...
National Center Reports Increase in Medical Device Adverse Event Reports for 2022
The National Center for Adverse Event Monitoring has released its national annual report regarding the...
China’s NMPA, MPS, and NHC Announce Updates to Narcotics and Psychotropic Substances Catalog
The National Medical Products Administration (NMPA), Ministry of Public Security, and National Health Commission have...
Hainan Introduces Management Regulations for Urgently Needed Import Drugs and Devices in Boao Lecheng
The Hainan provincial government has issued a Notice on the Management Regulations for Clinically Urgently...
NHC Proposes Updates to Access Standards for Class A and B Medical Equipment
The National Healthcare Commission (NHC) has released two proposed updates to the Access Standards for...
Round 8 VBP Tender Results: RMB 3.775 Billion Awarded Across 152 Manufacturers
The official results of Round 8 of China’s national Volume-Based Procurement (VBP) tender program have...
Hubei Implements Inter-Provincial VBP Tender Results for Pacemakers
The Hubei provincial Drug and Instrument Procurement Platform has issued a notice regarding the implementation...
NHC Report: Performance Assessment of National Class 2 Public Hospitals in 2021
The National Health Commission (NHC) has released the “Report on the National Monitoring and Analysis...
Hebei Leads Sanming Alliance in Launching 8th VBP for 19 Medical Consumables
The Hebei medical drug and device centralized procurement center has announced the start of the...
FDA Issues Complete Response Letters to Six Novel Drugs in Q1 2023
According to an analysis, the US FDA issued complete response letters (CRLs) to six novel...
Henan Province Sees 53.6% Price Reduction in Neuro and Peripheral Intervention Consumables Tender
The Henan Province Public Resources Trading Center has released a notification regarding the completion of...
Indonesia and China Deepen Healthcare Ties with High-Level Dialogue and New Agreements
Indonesia’s deputy minister of health, Dante Saksono Harbuwono, visited China last week as part of...
Shanxi Province Begins Historical Procurement Data Collection for Pacemaker VBP Round
In preparation for a volume-based procurement (VBP) round, Shanxi province has initiated the gathering of...
Fujian Healthcare Security Bureau Updates Sunshine Procurement Mechanism for Drugs
The Fujian Provincial Healthcare Security Bureau has released the Notice on Adjusting and Improving the...
China’s Provincial Governments Implement Second Batch of National Drug Use Monitoring Policy
In line with a notification issued by the National Health Commission (NHC) in January, provincial...
Provincial Budgets Highlight Top Earning Hospitals in China for 2023
Provincial governments have revealed the budget for provincial hospitals’ expected income during 2023, offering a...